| Dr Terance Moore, PHARMD | |
|
1155 E Pershing Rd, Decatur, IL 62526-4726 | |
| (217) 877-2374 | |
| (217) 877-0117 |
| Full Name | Dr Terance Moore |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1155 E Pershing Rd, Decatur, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063786176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH024043 (Georgia) | Primary |
| 183500000X | Pharmacist | 051295224 (Illinois) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Terance Moore, PHARMD 1155 E Pershing Rd, Decatur, IL 62526-4726 Ph: (217) 877-2374 | Dr Terance Moore, PHARMD 1155 E Pershing Rd, Decatur, IL 62526-4726 Ph: (217) 877-2374 |
News Archive
The Congressional Budget Office announcement May 11, 2010, that the Patient Protection and Affordable Care Act (Obamacare) would cost, over the next ten years, $115 Billion more, brings the total cost over $1 Trillion. Imagine—Congress and the President spent a whole year jamming a 2,309 page monster down our throats on the pretense of "eliminating fraud, waste and abuse (in the delivery of medical care) at a lower cost". This same Congressional Budget Office, using the contrived numbers given by Congress, had previously said Obamacare would REDUCE federal deficits by $143 Billion. I smell FRAUD.
KAEL-GemVax, a leading oncology vaccine company, today announced, through its subsidiary GemVax A.S, encouraging interim progress from the UK-based Phase III TeloVac study of its anti-telomerase therapeutic cancer vaccine GV1001 in pancreatic cancer. The company also strongly believes GV1001 has major "blockbuster" potential as a universal therapeutic cancer vaccine and is developing a strong pipeline for other indications, including lung and liver cancer and melanoma.
A Johns Hopkins University biologist has led a research team reporting progress in understanding the mysterious shape-shifting ways of stem cells, which have vast potential for medical research and disease treatment.
​Healthcare professionals and academic researchers will have the opportunity to hear from research teams at Plymouth Hospitals NHS Trust and its research partners next month.
Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that is developing a wide range of vaccines for infectious diseases prevalent in emerging economies.
› Verified 1 days ago
Ms. Halley Siedra Connor, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 625 W Pershing Rd, Decatur, IL 62526 Phone: 217-875-2751 Fax: 217-875-6631 | |
Kimberly Riggen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1315 N Water St, Decatur, IL 62526 Phone: 217-429-0958 | |
Dr. Jamie Leigh Hartman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1595 E Cantrell St, Decatur, IL 62521 Phone: 217-429-4248 | |
Caleb David Braasch, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1818 South Airport Rd, Decatur, IL 62521 Phone: 217-864-5912 | |
Whitney Miller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 225 East Ash Ave, Decatur, IL 62526 Phone: 217-872-1758 | |
Mr. David Mark Mattiuz, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1315 N Water St, Decatur, IL 62526 Phone: 217-429-0958 Fax: 217-429-1096 |